CERE - AbbVie slips after revising guidance to reflect earnings impact
2024-04-04 15:12:29 ET
More on AbbVie
- AbbVie Inc. (ABBV) Barclays 26th Annual Global Healthcare Conference (Transcript)
- AbbVie: Comeback Expected After Humira Patent Expiration
- AbbVie Stock: I Was So Wrong, But This Is Way Too Fast
- Aldeyra gains as Oppenheimer upgrades on revised plans for lead asset
- Aldeyra gains on plans for AbbVie-partnered eye disease drug